Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fred Hassan stay on as IFPMA head

This article was originally published in Scrip

Executive Summary

Fred Hassan, chairman and CEO of Schering-Plough, has been elected to a second two-year term as president of the International Federation of Pharmaceutical Manufacturers and Associations. He was first elected in 2006 to replace Dr Daniel Vasella of Novartis. Haruo Naito, president and CEO of Eisai was re-elected vice-president. David Brennan, CEO of AstraZeneca, has also been elected vice-president, replacing Dr Alessandro Banchi, who is stepping down as an IFPMA officer and retiring from Boehringer Ingelheim at the end of the year. Earlier this year, Alicia Greenidge was named director-general of the association, succeeding Dr Harvey Bale.

You may also be interested in...



Cervarix link to UK girl's death "unlikely"

Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.

Generic Topamax launched in European markets

Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.

NICE confirms limits on Alimta for lung cancer

Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.

Related Companies

UsernamePublicRestriction

Register

SC032101

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel